Difference between revisions of "Encainide"
From Self-sufficiency
m (Stub sorting and placement of stub template(s)) |
m (1 revision) |
(No difference)
| |
Latest revision as of 16:48, 19 September 2010
 | This article does not cite any references or sources. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. (December 2009) |
| File:Encainide.svg | |
| Systematic (IUPAC) name | |
|---|---|
|
4-methoxy-N-[2-(1-methyl-2-piperidin-1-ylethyl)phenyl]benzamide | |
| Identifiers | |
| CAS Number | 66778-36-7 |
| ATC code | C01BC08 (WHO) |
| PubChem | CID 48041 |
| DrugBank | APRD00613 |
| Chemical data | |
| Formula | C22H28N2O2 |
| Molar mass | 352.47 g/mol[[Script error: No such module "String".]] |
| Script error: No such module "collapsible list". | |
Encainide is a class Ic antiarrhythmic agent. It is no longer used because its frequent proarrhythmic side effects.
| 30px | This drug article relating to the cardiovascular system is a stub. You can help ssf by expanding it. |
Categories:
- Pages with script errors
- Articles lacking sources from December 2009
- Articles with invalid date parameter in template
- All articles lacking sources
- Pages with broken file links
- Infobox drug tracked parameters
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- 2Fix
- Antiarrhythmic agents
- Piperidines
- Sodium channel blockers
- Benzanilides
- Phenol ethers
- Cardiovascular system drug stubs
